165 related articles for article (PubMed ID: 20024502)
41. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.
Yang L; Sun MF; Gailani D; Rezaie AR
Biochemistry; 2009 Feb; 48(7):1517-24. PubMed ID: 19178150
[TBL] [Abstract][Full Text] [Related]
42. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
43. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
Desai UR; Petitou M; Björk I; Olson ST
J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
[TBL] [Abstract][Full Text] [Related]
45. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
46. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
Kurachi K; Fujikawa K; Schmer G; Davie EW
Biochemistry; 1976 Jan; 15(2):373-7. PubMed ID: 1247523
[TBL] [Abstract][Full Text] [Related]
49. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
50. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
Misenheimer TM; Buyue Y; Sheehan JP
Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
[TBL] [Abstract][Full Text] [Related]
51. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
52. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Olson ST; Rezaie AR
J Biol Chem; 2003 Jul; 278(27):25032-8. PubMed ID: 12721300
[TBL] [Abstract][Full Text] [Related]
53. Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III.
Scott CF; Schapira M; Colman RW
Blood; 1982 Oct; 60(4):940-7. PubMed ID: 7115961
[TBL] [Abstract][Full Text] [Related]
54. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.
Rashid Q; Singh P; Abid M; Jairajpuri MA
J Thromb Thrombolysis; 2012 Aug; 34(2):251-9. PubMed ID: 22453684
[TBL] [Abstract][Full Text] [Related]
55. The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides.
Barrowcliffe TW; Havercroft SJ; Kemball-Cook G; Lindahl U
Biochem J; 1987 Apr; 243(1):31-7. PubMed ID: 3606581
[TBL] [Abstract][Full Text] [Related]
56. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.
Bedsted T; Swanson R; Chuang YJ; Bock PE; Björk I; Olson ST
Biochemistry; 2003 Jul; 42(27):8143-52. PubMed ID: 12846563
[TBL] [Abstract][Full Text] [Related]
57. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
[TBL] [Abstract][Full Text] [Related]
58. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
59. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
60. Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificity.
Rezaie AR
J Biol Chem; 1996 Sep; 271(39):23807-14. PubMed ID: 8798609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
